India · Delayed Price · Currency is INR H&E Equipment Services Statistics
Total Valuation
NSE:MAXHEALTH has a market cap or net worth of INR 1.21 trillion. The enterprise value is 1.24 trillion.
| Market Cap | 1.21T |
| Enterprise Value | 1.24T |
Important Dates
The next estimated earnings date is Wednesday, August 6, 2025.
| Earnings Date | Aug 6, 2025 |
| Ex-Dividend Date | Jul 4, 2025 |
Share Statistics
| Current Share Class | 972.15M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.20% |
| Shares Change (QoQ) | -0.02% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 677.53M |
Valuation Ratios
The trailing PE ratio is 112.67 and the forward PE ratio is 66.63.
| PE Ratio | 112.67 |
| Forward PE | 66.63 |
| PS Ratio | 17.25 |
| PB Ratio | 12.92 |
| P/TBV Ratio | 36.23 |
| P/FCF Ratio | 245.50 |
| P/OCF Ratio | 83.07 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 65.75, with an EV/FCF ratio of 250.25.
| EV / Earnings | 114.86 |
| EV / Sales | 17.58 |
| EV / EBITDA | 65.75 |
| EV / EBIT | 80.90 |
| EV / FCF | 250.25 |
Financial Position
The company has a current ratio of 0.88, with a Debt / Equity ratio of 0.32.
| Current Ratio | 0.88 |
| Quick Ratio | 0.78 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | 1.60 |
| Debt / FCF | 6.10 |
| Interest Coverage | 10.27 |
Financial Efficiency
Return on equity (ROE) is 12.10% and return on invested capital (ROIC) is 8.64%.
| Return on Equity (ROE) | 12.10% |
| Return on Assets (ROA) | 7.02% |
| Return on Invested Capital (ROIC) | 8.64% |
| Return on Capital Employed (ROCE) | 11.40% |
| Revenue Per Employee | 4.65M |
| Profits Per Employee | 711,843 |
| Employee Count | 15,114 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 28.50 |
Taxes
In the past 12 months, NSE:MAXHEALTH has paid 3.30 billion in taxes.
| Income Tax | 3.30B |
| Effective Tax Rate | 23.50% |
Stock Price Statistics
The stock price has increased by +35.10% in the last 52 weeks. The beta is 0.29, so NSE:MAXHEALTH's price volatility has been lower than the market average.
| Beta (5Y) | 0.29 |
| 52-Week Price Change | +35.10% |
| 50-Day Moving Average | 1,224.21 |
| 200-Day Moving Average | 1,111.46 |
| Relative Strength Index (RSI) | 49.84 |
| Average Volume (20 Days) | 1,747,688 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:MAXHEALTH had revenue of INR 70.28 billion and earned 10.76 billion in profits. Earnings per share was 11.01.
| Revenue | 70.28B |
| Gross Profit | 43.77B |
| Operating Income | 15.28B |
| Pretax Income | 14.06B |
| Net Income | 10.76B |
| EBITDA | 18.31B |
| EBIT | 15.28B |
| Earnings Per Share (EPS) | 11.01 |
Balance Sheet
The company has 6.62 billion in cash and 30.10 billion in debt, giving a net cash position of -23.49 billion.
| Cash & Cash Equivalents | 6.62B |
| Total Debt | 30.10B |
| Net Cash | -23.49B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 93.81B |
| Book Value Per Share | 96.50 |
| Working Capital | -2.21B |
Cash Flow
In the last 12 months, operating cash flow was 14.59 billion and capital expenditures -9.66 billion, giving a free cash flow of 4.94 billion.
| Operating Cash Flow | 14.59B |
| Capital Expenditures | -9.66B |
| Free Cash Flow | 4.94B |
| FCF Per Share | n/a |
Margins
Gross margin is 62.28%, with operating and profit margins of 21.73% and 15.31%.
| Gross Margin | 62.28% |
| Operating Margin | 21.73% |
| Pretax Margin | 20.01% |
| Profit Margin | 15.31% |
| EBITDA Margin | 26.05% |
| EBIT Margin | 21.73% |
| FCF Margin | 7.03% |
Dividends & Yields
This stock pays an annual dividend of 1.50, which amounts to a dividend yield of 0.12%.
| Dividend Per Share | 1.50 |
| Dividend Yield | 0.12% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 2 |
| Payout Ratio | 13.53% |
| Buyback Yield | -0.20% |
| Shareholder Yield | -0.08% |
| Earnings Yield | 0.89% |
| FCF Yield | 0.41% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NSE:MAXHEALTH has an Altman Z-Score of 10.68 and a Piotroski F-Score of 6.
| Altman Z-Score | 10.68 |
| Piotroski F-Score | 6 |